B. Metzler seel. Sohn & Co’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17M Sell
606,068
-33,571
-5% -$894K 0.16% 78
2025
Q4
$15.9M Buy
639,639
+71,251
+13% +$1.8M 0.14% 86
2025
Q3
$14.5M Buy
568,388
+5,653
+1% +$140K 0.13% 86
2025
Q2
$13.6M Buy
562,735
+24,183
+4% +$564K 0.13% 83
2025
Q1
$13.6M Buy
538,552
+154,288
+40% +$4.04M 0.14% 83
2024
Q4
$10.2M Sell
384,264
-69,227
-15% -$1.88M 0.1% 101
2024
Q3
$13.1M Buy
453,491
+43,963
+11% +$1.28M 0.13% 96
2024
Q2
$11.5M Buy
409,528
+5,145
+1% +$142K 0.11% 93
2024
Q1
$11.1M Sell
404,383
-41,634
-9% -$1.16M 0.12% 97
2023
Q4
$12.8M Sell
446,017
-30,184
-6% -$912K 0.16% 78
2023
Q3
$15.8M Buy
476,201
+12,921
+3% +$457K 0.24% 60
2023
Q2
$17M Sell
463,280
-20,205
-4% -$786K 0.23% 61
2023
Q1
$19.7M Sell
483,485
-89,667
-16% -$3.87M 0.31% 56
2022
Q4
$29.4M Sell
573,152
-14,571
-2% -$699K 0.5% 39
2022
Q3
$25.7M Sell
587,723
-6,181
-1% -$300K 0.47% 42
2022
Q2
$31.1M Buy
593,904
+77,845
+15% +$3.97M 0.51% 36
2022
Q1
$26.7M Sell
516,059
-175,720
-25% -$9.12M 0.36% 51
2021
Q4
$40.4M Sell
691,779
-3,670,962
-84% -$182M 0.53% 37
2021
Q3
$188M Sell
4,362,741
-1,690,420
-28% -$74.9M 2.72% 8
2021
Q2
$237M Buy
6,053,161
+350,372
+6% +$13.6M 3.53% 5
2021
Q1
$210M Buy
5,702,789
+1,273,658
+29% +$45.2M 3.45% 8
2020
Q4
$163M Buy
+4,429,131
New +$162M 3.03% 7

Other funds holding PFE

B. Metzler seel. Sohn & Co's PFE Position: Q1 2026 in Review

B. Metzler seel. Sohn & Co reduced its Pfizer (PFE) stake by 5.2% in Q1 2026, selling an estimated $894K and leaving 606,068 shares worth $17M. The position accounts for 0.16% of the portfolio, ranked #78.

B. Metzler seel. Sohn & Co first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $237M in Q2 2021. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • B. Metzler seel. Sohn & Co held 606,068 shares of Pfizer worth $17M as of Q1 2026.
  • B. Metzler seel. Sohn & Co sold 33,571 Pfizer shares in Q1 2026, an estimated $894K.
  • Pfizer made up 0.16% of B. Metzler seel. Sohn & Co's portfolio in Q1 2026, its #78 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • B. Metzler seel. Sohn & Co's Pfizer position peaked at $237M in Q2 2021.
  • 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2026, filed 8 May 2026.